Wedbush Securities’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,258
| Closed | -$237K | – | 1143 |
|
|
2022
Q1 | $237K | Sell |
3,258
-196
| -6% | -$14.3K | 0.01% | 909 |
|
|
2021
Q4 | $408K | Buy |
3,454
+7
| +0.2% | +$827 | 0.02% | 722 |
|
|
2021
Q3 | $462K | Sell |
3,447
-394
| -10% | -$52.8K | 0.02% | 649 |
|
|
2021
Q2 | $622K | Sell |
3,841
-5,146
| -57% | -$833K | 0.03% | 536 |
|
|
2021
Q1 | $721K | Buy |
+8,987
| New | +$721K | 0.04% | 434 |
|